John Alam, MD – Chief Govt Officer of CervoMed Inc. CRVO, was lately a visitor on Benzinga’s All-Entry.
CervoMed is a clinical-stage firm devoted to the event and commercialization of focused drug therapies for neurodegenerative illnesses with a deal with the early phases of the illness course of.
Mr. Alam spoke of the promising topline outcomes from the continuing section 2b trial of its lead drug candidate.
Watch the complete interview right here:
Featured photograph by JD Mason on Unsplash.
This publish accommodates sponsored content material. This content material is for informational functions solely and isn’t supposed to be investing recommendation.
Market Information and Information delivered to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga doesn’t present funding recommendation. All rights reserved.
